SUMMARY -In patients with atherosclerotic stenosis of the extracranial segment of internal carotid artery, surgical intervention is an eff ective method to prevent cerebral ischemic stroke. However, this surgical procedure may cause vascular brain damage. Th e aim of the study was to investigate consequential brain ischemia-reperfusion injury by measuring the cerebral specifi c marker, neuronspecifi c enolase (NSE), in serum of patients having undergone internal carotid endarterectomy (CEA). Th e study involved 25 patients that underwent CEA due to internal carotid artery stenosis. Blood samples were obtained from each patient on three occasions: within 24 h prior to surgery, 12 h after surgery, and 48 h after surgery. Serum NSE levels were measured by a commercially available enzymelinked immunosorbent assay. Th e study showed that serum NSE level was statistically signifi cantly increased 48 h after CEA as compared with the level 12 h after surgery and the level before surgery (p<0.05). Diff erence in serum NSE between the level before surgery and 12 h after CEA was not statistically signifi cant (p>0.05). Data from our study showed CEA to aff ect serum NSE in patients with signifi cant internal carotid artery stenosis. Th us, serum NSE may be used as a biochemical marker of brain ischemia-reperfusion injury following CEA.
Introduction
Stroke including ischemic stroke is one of the major public health problems worldwide, particularly in industrialized countries. Strokes are a frequent cause of acute hospitalization, severe morbidity, and the third cause of overall mortality 1 . Surgical treatment of atherosclerotic stenosis of the extracranial segment of internal carotid artery is an effective method of preventing cerebral ischemic stroke 2 . However, it should be noted that the procedure is burdened with the consequences of neurological complications during the perioperative period. Microembolisms, macroembolisms, and increased or decreased blood fl ow to the brain as a result of internal carotid artery endarterectomy (CEA) may lead to ischemic and/or hyperperfusion brain damage [3] [4] [5] . Neuron-specifi c enolase (NSE) is a dimeric isoenzyme of the glycolytic enzyme enolase. NSE has a molecular weight of approximately 80 kDa and is found mainly in the neurons and cells of the neuroendocrine system. It participates in slow axoplasmic transport. NSE is not normally secreted, but when axons are damaged, NSE is upregulated to maintain homeostasis. Th erefore, NSE is the only marker that directly assesses functional damage to neurons. As NSE is mainly found in neurons, its level in serum or cerebrospinal fl uid (CSF) may be elevated in neurological diseases. According to Jauch et al., biochemical markers of acute neuronal injury including NSE may play a role in the diagnosis and management of cerebral ischemia. Th e authors observed increased 24-h peak levels of NSE that were associated with higher than normal baseline scores set forth by the National Institutes of Health Stroke Scale. Moreover, serum NSE may have a prognostic value in traumatic brain injury. Unfavorable outcomes and mortality of patients were signifi cantly associated with increased serum NSE levels. It is also concluded that NSE has a moderate discriminatory ability to predict mortality and neurological outcome in patients with traumatic brain injury 6, 7 . Th erefore, NSE may also be a biochemical marker of brain ischemia-reperfusion injury in patients undergoing CEA. Th e aim of the study was to investigate serum NSE levels and its changes over time in these patients.
Patients and Methods
Th e study involved patients hospitalized in the Department of Vascular Surgery and Angiology, Medical University of Lublin, Lublin, Poland, undergoing CEA due to internal carotid artery stenosis. Patients were qualifi ed for surgical treatment according to the guidelines of the European Society of Vascular Surgery based on Doppler studies performed using a Toshiba Aplio 500 ultrasound 8 . Patients with high grade stenotic carotid arteries were identifi ed and measured by using the guidelines set by the North American Symptomatic Carotid Endarterectomy Trial (NASCET) 9 . Th e study group consisted of 25 participants (15 male and 10 female) aged from 54 to 88 years, average 69 years. Patients with occlusion of the internal carotid artery were not qualifi ed for surgery and research. Th e degree of internal carotid artery stenosis ranged from 60% to 90%. Th e average clamping time of internal carotid artery during CEA was 8.5 minutes. Conventional CEA was performed under local anesthesia. Shunt was not used. No complications associated with CEA were observed. Th e mean velocity of blood fl ow in the internal carotid artery was 208.4 cm/s (blood fl ow 1) before surgery and 89.5 cm/s (blood fl ow 2) after surgery. Past medical histories of study subjects included previous ischemic stroke (n=8), transient ischemic attack (n=7), and asymptomatic internal carotid artery stenosis (n=10). Th e study criteria disqualifi ed patients with known organic brain damage in the course of various diseases of the nervous system (e.g., multiple sclerosis, Alzheimer's disease).
Blood samples were obtained from each patient from the antecubital vein on three occasions: within 24 h prior to surgery (NSE 1), 12 h after surgery (NSE 2), and 48 h after surgery (NSE 3). Serum samples were collected into plastic tubes, centrifuged rapidly, and stored at -80 ˚C until analysis. Serum NSE levels were measured by a commercially available enzyme-linked immunosorbent assay (Enzyme-Linked Immunosorbent Assay Kit for Enolase, Neuron Specifi c (NSE), Cloud Clone Corp./USCN, Houston, TX, USA).
Statistical analysis was performed using STATIS-TICA version 10 software (StatSoft, Inc., Poland). Distribution of the collected data was evaluated using the Shapiro-Wilk's test. Furthermore, data on the NSE levels were analyzed using ANOVA with post hoc Tukey HSD test. For the dichotomous system, Student's t-test and Mann-Whitney U test (depending on the distribution obtained) were used to examine between-group diff erences. Correlation analysis was performed using the Spearman rank correlation. Th e NSE values were expressed in ng/mL. Th e values of p<0.05 were considered signifi cant.
Th e study was approved by the Ethics Committee of Medical University in Lublin (KE-0254/218/2014).
Results
Th e ANOVA test showed that sampling time signifi cantly aff ected serum NSE levels (p<0.05). Serum NSE levels and comparative analysis are presented in Table 1 .
Th e post hoc Tukey HSD test revealed that serum NSE level was statistically signifi cantly increased 48 h after CEA as compared with the levels measured 12 h after surgery and prior to surgery (p<0.05). However, diff erence in serum NSE levels prior to surgery and 12 h after CEA was not statistically signifi cant (p>0.05) ( Table 2) .
Th ere was no statistically signifi cant diff erence in serum NSE levels between symptomatic and asymptomatic patients (p>0.05). Th ere was no statistically signifi cant correlation between serum NSE levels and clamping time either (p>0.05).
Th ere was no statistically signifi cant correlation of serum NSE levels with blood fl ow velocity in internal 
Fig. 1. Correlation between neuron-specifi c enolase (NSE) NSE 2/NSE 3 levels and blood fl ow velocity in internal carotid artery.
carotid artery before CEA and after surgery (p>0.05) ( Table 3) . However, change in the blood fl ow calculated as: [(blood fl ow rate after surgery -blood fl ow rate prior to surgery)/blood fl ow rate prior to surgery]*100 and change in the NSE2 and NSE3 levels indicated statistically signifi cant correlations (r=0.45, p=0.0239; and r=0.41, p=0.0394, respectively). Th e correlation between NSE2/NSE3 levels and blood fl ow velocity in internal carotid artery is illustrated in Figure 1 .
Discussion
Our study revealed that serum NSE level was statistically signifi cantly increased 48 h after CEA as compared with the levels 12 h after surgery and prior to surgery. Dragas et al. 10 observed that changes in serum NSE occurred after CEA. Th e authors concluded that serum NSE could be used as a potential marker of brain injury after surgery. Capoccia et al. 11 investigated the relationship between serum levels of two biochemical markers of cerebral injury, S100 protein and NSE, using postoperative diff usion-weighted magnetic resonance imaging, and neuropsychometric testing in patients undergoing CEA or carotid artery stenting (CAS). Th e authors observed that the aforementioned biochemical markers were signifi cantly increased at 24 h in CAS patients as compared with CEA patients. According to the authors, the increased S100 and NSE levels following CAS may be caused by perioperative microembolization rather than hypoperfusion. Brightwell et al. 12 measured serum S-100b and NSE levels in patients undergoing CEA and CAS, and found associated hemodynamic and embolic events detected using transcranial Doppler (TCD). TCD fi ndings showed that the mechanisms of these increased biochemical markers may have diff ered, and thus may have been caused by microembolization and cerebral hypoperfusion, respectively. According to the authors, cerebral hypoperfusion is responsible for the increase of the above mentioned brain damage markers in cases related to CEA.
Serum levels of NSE were measured intraoperatively, prior to and after carotid clamping. Th ere was no diff erence in subtle cerebral damage between patients randomized to receive a shunt or not 13 . Gao et al.
14 studied NSE levels in serum of patients before, during, and for 2 days after CEA performed under general anesthesia and incorporating the use of a Javid shunt. Serum NSE level increased during shunting, while the CSF NSE level did not change. Diff erent results were obtained in studies conducted by Rasmussen et al. 15 . Th e authors measured serum levels of NSE in patients before CEA and postoperatively at 12, 24, 36 and 48 h. Compared with abdominal aortic surgery patients, the preoperative serum level of NSE was signifi cantly higher in carotid artery surgery patients. Postoperatively, serum NSE level decreased signifi cantly after uncomplicated CEA, and the level was then similar to that in the aortic surgery patients. Th e authors concluded that subtle brain damage after carotid artery surgery could not be detected by measuring blood levels of NSE.
Th e mechanism of serum NSE elevation observed in our study is unknown, but we support the hypothesis that increased blood-brain barrier permeability caused by hypoxia during carotid cross-clamping may infl uence NSE leaking from the brain into the blood.
Cerebral damage during carotid clamping may be the result of microembolism and/or hypoperfusion. Elevated serum NSE levels may refl ect ischemia-induced enzyme loss. An increase in serum NSE level may also be caused by hyperperfusion brain damage during CEA. In many patients, clamping of the internal carotid artery during CEA results in transient decrease in cerebral blood fl ow in the ipsilateral cerebral hemisphere 16 . If this decrease in the hemispheric cerebral blood fl ow is signifi cant enough to impair autoregulation, then consequently ipsilateral cerebral hyperperfusion can occur after internal carotid artery declamping. Development of cerebral hyperperfusion after CEA is associated with preoperative hemodynamic impairment and intraoperative cerebral ischemia 17 . It has been suggested that acute ischemia and reperfusion by clamping and declamping of the internal carotid artery may produce oxygen-derived free radicals resulting in impairment of cerebrovascular autoregulation, postischemic hyperperfusion, or/and brain edema 18, 19 .
Brouns et al. 20 investigated CSF levels of diff erent neuromarkers including NSE in acute ischemic stroke patients and their relation to initial stroke severity, stroke location, and long-term stroke outcome. Th ey concluded that biomarkers displayed relevant diff erences in cellular and subcellular origins, which were refl ected in their relation to stroke characteristics.
In conclusion, data from our study showed that CEA aff ected serum NSE in patients with signifi cant internal carotid artery stenosis. Th us, serum NSE may be used as a biochemical marker of brain ischemia-reperfusion injury after CEA.
